USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | -18.85 Thousand | -39.73 Thousand |
Net Income | - | - | - | - | -30.26 Thousand | -35.88 Thousand |
Depreciation & Amortization | - | - | - | - | 400.00 | 367.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | 11 Thousand | -4220.00 |
Other non-cash items | - | - | - | - | -5388.00 | 2534.00 |
Investing Cash Flow | - | - | - | - | - | -1200.00 |
Investments in PPE | - | - | - | - | - | -1200.00 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | 17.87 Thousand | 38.75 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | 26.1 Thousand |
Other Financing Activities | - | - | - | - | 17.87 Thousand | 12.65 Thousand |
Accounts receivables | - | - | - | - | -576.00 | - |
Accounts payables | - | - | - | - | 7264.00 | 100.00 |
Inventory | - | - | - | - | 4.32 | -4320.00 |
Other working capital | - | - | - | - | 11 Thousand | -4320.00 |
Cash at beginning of period | - | - | - | - | 986.00 | 3169.00 |
Cash at end of period | - | - | - | - | - | 986.00 |
Capital Expenditure | - | - | - | - | - | -1200.00 |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | -986.00 | -2183.00 |
Free Cash Flow | - | - | - | - | -18.85 Thousand | -40.93 Thousand |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2020 Q3 | 2020 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -7595.00 | -16.66 Thousand |
Depreciation & Amortization | - | - | - | - | 100.00 | 100.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | 3595.00 | 404.00 |
Other non-cash items | - | - | - | - | 3.70 | 0.55 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | 3900.00 | 16.16 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 3900.00 | 16.16 Thousand |
Accounts receivables | - | - | - | - | - | -0.05 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | -3900.00 | -16.16 Thousand |
CLB
ACRV
300108
AB9
603166
6130